SEC Comment Letter 0000000000-24-001010 to AKANDA CORP. (AKAN)
AKANDA CORP.
Date: Jan. 25, 2024 · CIK: 0001888014 · Accession: 0000000000-24-001010
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276577
Letter
United States securities and exchange commission logo January 25, 2024 Katie Field Interim Chief Executive Officer Akanda Corp. 1a, 1b Learoyd Road New Romney, TN28 8XU Re:Akanda Corp. Registration Statement on Form F-3 Filed January 18, 2024 File No. 333-276577 Dear Katie Field: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mark Lee, Esq.
Show Raw Text
United States securities and exchange commission logo
January 25, 2024
Katie Field
Interim Chief Executive Officer
Akanda Corp.
1a, 1b Learoyd Road
New Romney, TN28 8XU
Re:Akanda Corp.
Registration Statement on Form F-3
Filed January 18, 2024
File No. 333-276577
Dear Katie Field:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mark Lee, Esq.